Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Yes1 associated transcriptional regulator, YAP1, is a key nuclear effector in the Hippo signaling pathway. It functions as a transcriptional co-activator, promoting cell proliferation and inhibiting apoptosis by interacting with TEAD family transcription factors. YAP1 plays a critical role in regulating organ size, tissue growth, and homeostasis, and is implicated in multiple cancers due to its pro-tumorigenic activity.
Inhibition of YAP1 transcriptional activity, reduction of YAP1 expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Yes1 associated transcriptional regulator (YAP1).